CGRP-monoclonal antibodies and SARS-CoV-2 vaccination

被引：0
|
作者：
Francesca Schiano di Cola
Salvatore Caratozzolo
Paolo Liberini
Alessandro Padovani
Renata Rao
机构：
[1] University of Brescia,Neurology Unit, Department of Clinical and Experimental Sciences
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2848 / 2849
页数：1
相关论文
共 50 条
  • [21] SARS-CoV-2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
    Boskovic, Marko
    Migo, William
    Likic, Robert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4476 - 4478
  • [22] CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
    Francesca Schiano di Cola
    Salvatore Caratozzolo
    Marco Bolchini
    Giulia Ceccardi
    Matteo Cortinovis
    Paolo Liberini
    Alessandro Padovani
    Renata Rao
    Neurological Sciences, 2022, 43 : 5763 - 5764
  • [23] Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection
    Bruzzesi, Elena
    Ranzenigo, Martina
    Castagna, Antonella
    Spagnuolo, Vincenzo
    NEW MICROBIOLOGICA, 2021, 44 (03): : 135 - 144
  • [24] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
    Sonu Kumar
    Debrupa Dutta
    Velayutham Ravichandiran
    Soumi Sukla
    3 Biotech, 2022, 12
  • [25] Monoclonal neutralizing antibodies against SARS-COV-2 S protein
    Cheng, Lin-Dong
    Li, Ping
    Lin, Yan-Chen
    Hu, Hui-Xiu
    Zhang, Ying
    Li, Hou-Feng
    Huang, Jing
    Tan, Li
    Ma, Ning
    Xia, Deng-Yun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (02): : 681 - 689
  • [26] Development of SARS-CoV-2 specific neutralizing recombinant monoclonal antibodies
    Desai, Pavitra
    Karuppuchamy, Thangaraj
    Syed, Nazia
    Unnikrishnan, Sarath
    Mathivanan, Raghul
    Priya, Nancy
    Balasubramanian, Rajesh
    Bhattiprolu, Krishna
    Sundarraj, Swathi
    Sridharan, Haripriya
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [27] Monoclonal antibodies neutralizing circulating SARS-CoV-2 variants of concern
    Kovacech, Branislav
    Fialova, Lubica
    Filipcik, Peter
    Skrabana, Rostislav
    Zilkova, Monika
    Kovac, Andrej
    Rolkova, Gabriela Paulikova
    Tomkova, Katarina
    Csokova, Natalia Turic
    Markova, Karina
    Skrabanova, Michaela
    Majerova, Petra
    Hanes, Jozef
    Cehlar, Ondrej
    Cente, Martin
    Piestansky, Juraj
    Slavikova, Monika
    Borsova, Kristina
    Cabanova, Viktoria
    Brejova, Bronislava
    Vinar, Tomas
    Nosek, Jozef
    Klempa, Boris
    Eyer, Ludek
    Honig, Vaclav
    Palus, Martin
    Ruzek, Daniel
    Vyhlidalova, Tereza
    Strakova, Petra
    Mrazkova, Blanka
    Zudova, Dagmar
    Koubkova, Gizela
    Novosadova, Vendula
    Prochazka, Jan
    Sedlacek, Radislav
    Zilka, Norbert
    Kontsekova, Eva
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 53 - 54
  • [28] Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
    Guo, Youjia
    Kawaguchi, Atsushi
    Takeshita, Masaru
    Sekiya, Takeshi
    Hirohama, Mikako
    Yamashita, Akio
    Siomi, Haruhiko
    Murano, Kensaku
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [29] Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
    Izadi, Arman
    Nordenfelt, Pontus
    TRENDS IN IMMUNOLOGY, 2024, 45 (08) : 609 - 624
  • [30] Current status of therapeutic monoclonal antibodies against SARS-CoV-2
    Kumar, Sanjeev
    Chandele, Anmol
    Sharma, Amit
    PLOS PATHOGENS, 2021, 17 (09)
12345